Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 08/24/16 | 8-K | Current report filing |
|
7 | |
| 08/19/16 | 8-K | Current report filing |
|
3 | |
| 07/20/16 | DEF 14A | Definitive proxy statements |
|
38 | |
| 07/19/16 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
   |
68 |
| 07/15/16 | 5 | Annual statement of changes in beneficial ownership of securities |
|
2 | |
| 07/08/16 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
35 | |
| 06/03/16 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/03/16 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/03/16 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/03/16 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
